Navigation Links
Acute lung injury patients one-third less likely to die in 'closed' model ICUs
Date:9/28/2007

to co-manage on all patients. The remaining third received care at open ICUs, where cases could be managed by any attending physicians with admitting privileges, and pulmonary consultations were optional. According to the American College of Chest Physicians, only 25 percent of ICUs nationwide follow the closed model.

There were no significant differences in the degree of illness between patients who were cared for in closed versus open ICUs as measured by Acute Physiological and Chronic Health Evaluation III (APACHE III) scores, but patients at closed ICUs were younger and more likely to be male.

Patients cared for in a closed ICU had statistically significantly lower mortality than patients cared for in open ICUs, the researchers reported. Interestingly, the effect remained significant after adjusting for a number of variables in the analysis. While 77 percent of patients in closed ICUs were seen by a pulmonary consultant, consults alone did not have a significant effect on mortality. Similarly, adjusting for nurse-to-patient ratio and hospital volume of mechanically ventilated patients had no effect on mortality. Of patients treated in open ICUs, 45 percent died; in closed ICUs there was 35 percent mortality.

The investigators noted that because of the small sample size of hospitals and the date of the data collection, it would be difficult to extrapolate their results to a general trend among ICUs in the United States. Noting that the use of low tidal volume mechanical ventilation differed between closed and open ICUs, the researchers remarked that other unrecognized differences in patient care could exist, but that their results add support for the positive effect of a closed ICU model on patient outcome.

These findings add to the evidence of the important role of intensivist staffing in caring for critically ill patients, and support the recommendations to implement closed-model ICUs in the United States, said Dr. Treggia
'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Acute Measles Supresses HIV Replication
2. Severe Acute respiratory Syndrome (SARS)
3. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
4. Acute Pancreatitis On The Rise Due To Alcohol Consumption
5. Promised Drug Doesnt Help Acute Heart Failure
6. Atrial fibrillation predicts for acute ischaemic stroke
7. Antibiotics for acute uncomplicated lower respiratory tract infection
8. Handwashing prevents diarrhea and acute lower respiratory infections
9. Gene Fusion Test to screen children’s with Acute Lymphoblastic Leukemi
10. Protective regimen for acute Graft-versus-host disease
11. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...RNewswire/ -- Precyse Solutions, the leader in,dr...formance through,technology and management soluti...ncil of Pennsylvania as "Technology Company of the...the Kimmel Center. The Annual Gala honors the,re...and entrepreneurs. More,than 1200 business leade...
(Date:11/20/2008)...RNewswire-USNewswire/ -- In a historic step toward... for financing long-term services and supports, th... and the Consortium for Citizens with Disabilities...r reform. , , Together, the two coalitions...iors, people with disabilities, and providers of h...
(Date:11/20/2008)...nst infection that can cause meningitis, pneumonia.... 20 (HealthDay News) -- U.S. health officials sai...hem to monitor Hib infections, one of the most imp...en. , Though the agency has yet to see an incre...pted by a disruption in the supply of vaccine that...
(Date:11/20/2008)...20 Want to lower your risk for typ...0 minutes of physical activity,three times a day....t,s what,the U.S. Centers for Disease Control and...d pressure, manage your cholesterol and lose weigh...e people have diabetes, and heart,disease is the ...
Breaking Medicine News(10 mins):Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 3Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 4Health News:CDC Monitors Shortage of Hib Vaccine 2Health News:CDC Monitors Shortage of Hib Vaccine 3Health News:10 Minutes at a Time: Simple Steps to Get Moving and Reduce Your Risk of Diabetes and Heart Disease 2
...of the U.S. Congress called on Monday for more rig...struments.// The Food and Drug Administration (FD...ocessing -- but significant gaps remain, according...anking Democrat on the House Appropriations subcom...
...dy to deal with a nearly certain outbreak of a bir...rs, says a top EU medical expert.// Professor Jo...otection and Control (ECDC) was speaking after chi...f the 25 EU nations met to discuss protecting Euro...
...erican scientists has sparked new fears over the s...that they should eat no more than two portions a y...art of New York State University, concluded that t...g Scottish fish are outweighed by risks caused by ...
...mprovement in the motor symptoms of patients who s...mplants from the human retina, according to a stud...atients who suffer from the neurodegenerative diso... the symptoms under control. This is used for trea...
Other Medicine News:Health News:Scrutiny Sought For Reused Devices in U.S. 2Health News:EU medical chief says Europe ready for bird flu 2Health News:Salmon's own diet sure to affect yours 2
(Date:11/20/2008)...a from a prospective,registry presented this week...atment with the Trellis(R) Peripheral Infusion Sys... successfully breaks up the blood clot in most,pa...e, called isolated pharmacomechanical thrombolysis...n current catheter-directed thrombolysis,(CDT) te...
(Date:11/20/2008)...- The Scandinavian-based drug,development company...on its,lead antimicrobial candidate LTX-109. Pres...wed that the novel lytic peptidomimetic has an ult...er towards killing Staphylococcus,aureus and Stre...gs. In,addition to this it has proven effective a...
(Date:11/19/2008)...stCall/ -- Amgen,(Nasdaq: AMGN ) and Millennium...keda Pharmaceutical Company Limited (TSE: 4052), t...ET1 trial evaluating motesanib (AMG 706) in,combi...st-line treatment of,advanced non-small cell lung...llowing a planned safety data review of 600 patien...
(Date:11/19/2008)...ritical enzyme,s regulation may hold key to unders..., , MEMPHIS, Tenn., Nov. 19 /PRNewswire-USN...earch Hospital have gained new insights into regul...d calpains. , , As the cell,s molecular ov...ocesses, including the movement of cells in tissue...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3VA Announces 2436 Million in Grants for Homeless Programs 26666 1VA Announces 2436 Million in Grants for Homeless Programs 26666 2VA Announces 2436 Million in Grants for Homeless Programs 26666 3VA Announces 2436 Million in Grants for Homeless Programs 26666 4VA Announces 2436 Million in Grants for Homeless Programs 26666 5VA Announces 2436 Million in Grants for Homeless Programs 26666 6VA Announces 2436 Million in Grants for Homeless Programs 26666 7VA Announces 2436 Million in Grants for Homeless Programs 26666 8VA Announces 2436 Million in Grants for Homeless Programs 26666 9VA Announces 2436 Million in Grants for Homeless Programs 26666 10New Report 3A Ballot Measure 3 Will Reduce Smoking Save Lives and Save Money in North Dakota 26663 1New Report 3A Ballot Measure 3 Will Reduce Smoking Save Lives and Save Money in North Dakota 26663 2Justin Timberlake Promos Air on GOLF CHANNEL 26660 1A look to the future 26657 1A look to the future 26657 2
... 2007 - First-in-human results for,IMC-A12, a mono...porated (NASDAQ: IMCL) and targeted to IGF-1R (ins...sented at the annual,meeting of the American Socie...expressed on the cell surface of must human cancer...owth and,proliferation, and inhibition of programm...
... Nuclear Medicine Annual Meeting -, WASHINGTON, Ju..., Inc. , a biopharmaceutical company focused on,de... other serious,diseases, today announced that init...s humanized anti-MUC1 monoclonal antibody (hPAM4),... in patients with,unresectable and metastatic panc...
Other Medicine Technology:Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 2Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 3Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 2Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 3Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 4Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 5
Our suction kits include a Tri-Flo® suction catheter, a pop-up solution basin and two sturdy, precuffed latex exam gloves in an inner wallet. Infant and pediatric kits (5/6, 8 and 10 Fr) feature
Clear plastic sleeve envelopes a plastic suction catheter. Sleeve slides over exudate to reduce potential clinician contact.
The rubber, whistle tip catheter with thumb valve has two side eyes to help minimize trauma.
Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract.
Medicine Products: